Explore expert-vetted resources on diseases of mind and sight.
Get tips to facilitate the best possible communication with someone who has Alzheimer's disease.
Doctors who prescribe Leqembi, a new FDA-approved Alzheimer’s disease drug, are required to enroll their patients in a registry to obtain Medicare insurance coverage. Here are six facts to know about patient registries, including how your privacy is protected.
Learn helpful caregiver tips for the holiday season.
A discussion with Dr. Cynthia Lemere on the rapidly evolving landscape of available treatments for Alzheimer’s disease.
Leqembi, an FDA-approved amyloid-clearing drug, is offering renewed hope to people with early signs of dementia. Here’s what to know about it.
Learn about the role that genes play in the risk of developing the early- and late-onset forms of Alzheimer’s disease.
